Your Followed Topics

0.00%
science1w ago

Penn Medicine, Children's Hospital of Philadelphia team awarded Breakthrough Prize for developing gene therapy for inherited blindness

https://www.prnewswire.com/news-releases/penn-medicine-childrens-hospital-of-philadelphia-team-awarded-breakthrough-prize-for-developing-gene-therapy-for-inherited-blindness-302746319.htmlhttps://www.livescience.com/health/usd3-million-prize-goes-to-duo-whose-research-led-to-first-sickle-cell-crispr-therapyhttps://www.theguardian.com/science/2026/apr/19/the-oscar-of-science-awarded-to-scientists-behind-genetic-treatment-that-restores-lost-vision-win
Prnewswire.com and 3 more
Penn Medicine, Children's Hospital of Philadelphia team awarded Breakthrough Prize for developing gene therapy for inherited blindness Open in Prnewswire.com
Highlights
  • Casgevy edits patient blood stem cells to boost fetal hemoglobin, creating a functional cure pathway for sickle cell disease and beta-thalassemia.
  • The Breakthrough prizes, described by their Silicon Valley founders as the Oscars of science, were handed out on Saturday night at a glitzy ceremony in Los Angeles.
  • Luxturna’s patient-centered impact is shown when a child finally sees a loved one’s face, highlighting real-world benefits beyond theory.

Virality Score Timeline

Vote 4
0

References

$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy

$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy

‘Oscar of science’ awarded to team behind gene therapy that restores lost vision

‘Oscar of science’ awarded to team behind gene therapy that restores lost vision

Team behind gene therapy that restores lost vision win $3 million ‘Oscar of science’ award | LBC

Team behind gene therapy that restores lost vision win $3 million ‘Oscar of science’ award | LBC

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 943 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement